Effect of Mint and Mefnamic Acid on Menstrual Pai
Phase 3
Completed
- Conditions
- primary dysmenorrhea.Primary dysmenorrhoea
- Registration Number
- IRCT201011205206N1
- Lead Sponsor
- Hamadan University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- Female
- Target Recruitment
- 432
Inclusion Criteria
Inclusion Criteria: a) Primary dysmenorrhea; b) Single; c) 18-25 years old.
Exclusion criteria: a) Contraindication of mint including obstruction of common bile duct, allergy, cholecystitis, chronic liver disease, and gastroesophageal reflux, b) contraindication of mefenamic acid including: allergy, gastritis, gastric ulcer, chronic renal failure, chronic liver disease, anemia, asthma, diabetes mellitus.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Duration of Dysmenorrhea. Timepoint: After taking. Method of measurement: Standard questionnaire (COX).;Severity of Menstrual pain. Timepoint: After taking. Method of measurement: Standard questionnaire of pain violence(vas).;Amount of menstrual bleeding. Timepoint: End of menstrual periods. Method of measurement: Standard questionnaire of Hylgam menstrual bleeding.;Nausea. Timepoint: End of menstrual periods. Method of measurement: Questionnaire.;Vomiting. Timepoint: End of menstrual periods. Method of measurement: Questionnaire.;Diarrhea. Timepoint: End of menstrual periods. Method of measurement: Questionnaire.
- Secondary Outcome Measures
Name Time Method Side effects. Timepoint: After taking. Method of measurement: Questionnaire.